Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06NGA
|
||||
Former ID |
DNC003400
|
||||
Drug Name |
1,2,5-THIADIAZOLIDIN-3-ONE-1,1-DIOXIDE
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [551374] | ||
Structure |
Download2D MOL |
||||
Formula |
C2H4N2O3S
|
||||
Canonical SMILES |
C1C(=O)NS(=O)(=O)N1
|
||||
InChI |
1S/C2H4N2O3S/c5-2-1-3-8(6,7)4-2/h3H,1H2,(H,4,5)
|
||||
InChIKey |
JSZAZZQHDRHICK-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | mRNA of Protein tyrosine phosphatase-1B | Target Info | Inhibitor | [551374] | |
KEGG Pathway | Adherens junction | ||||
Insulin signaling pathway | |||||
NetPath Pathway | FSH Signaling Pathway | ||||
PANTHER Pathway | Cadherin signaling pathway | ||||
Pathway Interaction Database | Insulin Pathway | ||||
Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) | |||||
Signaling events mediated by PTP1B | |||||
Calcineurin-regulated NFAT-dependent transcription in lymphocytes | |||||
Signaling events mediated by TCPTP | |||||
IGF1 pathway | |||||
EGF receptor (ErbB1) signaling pathway | |||||
Posttranslational regulation of adherens junction stability and dissassembly | |||||
PDGFR-beta signaling pathway | |||||
N-cadherin signaling events | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.